n-acetylneuraminic acid has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asuthkar, S; Caniglia, JL; Guda, MR; Tsung, AJ; Velpula, KK | 1 |
1 review(s) available for n-acetylneuraminic acid and Cytokine Release Syndrome
| Article | Year |
|---|---|
Immunopathology of galectin-3: an increasingly promising target in COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Galectin 3; Humans; N-Acetylneuraminic Acid; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |